Thursday, July 16, 2015

Syngene International IPO to open on Jul 27th

Syngene International Ltd is entering in the capital markets with an initial public offering, IPO of 22,000,000 Equity Shares of Rs. 10 each. The price band for the issue has been fixed at Rs 240/- at lower level and Rs 250/- at upper level. The minimum bid lot is 60 equity shares and in multiples of 60 equity shares thereafter.

Syngene International, a subsidiary of Biocon Ltd is India-based contract research organisations ("CRO"), offering a suite of integrated, end-to-end discovery and development services for novel molecular entities ("NMEs") across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies.

The issue opens on Jul 27, 2015 and closes for subscription on Jul 29, 2015. The equity shares of the issue are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).